THRY vs. MDGL
THRY (Thryv Holdings, Inc.) and MDGL (Madrigal Pharmaceuticals, Inc.) are both stocks. THRY operates in Internet Content & Information (Communication Services), while MDGL operates in Biotechnology (Healthcare). Over the past 5 years, THRY returned -37.25%/yr vs 38.39%/yr for MDGL. At a 0.18 correlation, their price movements are largely independent.
Performance
THRY vs. MDGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THRY achieves a -44.30% return, which is significantly lower than MDGL's -11.93% return.
THRY
- 1D
- -3.71%
- 1M
- -15.11%
- YTD
- -44.30%
- 6M
- -43.55%
- 1Y
- -73.17%
- 3Y*
- -48.25%
- 5Y*
- -37.25%
- 10Y*
- —
MDGL
- 1D
- 1.41%
- 1M
- -0.85%
- YTD
- -11.93%
- 6M
- -14.92%
- 1Y
- 79.50%
- 3Y*
- 29.23%
- 5Y*
- 38.39%
- 10Y*
- 47.15%
THRY vs. MDGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
THRY Thryv Holdings, Inc. | -44.30% | -59.12% | -27.27% | 7.11% | -53.81% | 204.67% | -3.57% |
MDGL Madrigal Pharmaceuticals, Inc. | -11.93% | 88.72% | 33.36% | -20.28% | 242.52% | -23.77% | -6.37% |
Correlation
The correlation between THRY and MDGL is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2020 | 0.18 |
The correlation between THRY and MDGL shifts across timeframes, from 0.02 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
THRY:
$152.48M
MDGL:
$14.89B
THRY:
$0.33
MDGL:
-$12.87
THRY:
0.19
MDGL:
10.89
THRY:
0.68
MDGL:
27.40
THRY:
$771.33M
MDGL:
$1.13B
THRY:
$522.68M
MDGL:
$1.05B
THRY:
$81.86M
MDGL:
-$287.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THRY vs. MDGL — Risk / Return Rank
THRY
MDGL
THRY vs. MDGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Thryv Holdings, Inc. (THRY) and Madrigal Pharmaceuticals, Inc. (MDGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| THRY | MDGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.61 | ||
| Sortino ratioReturn per unit of downside risk | -3.88 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.32 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | 2.72 | -3.59 |
| Martin ratioReturn relative to average drawdown | -1.32 | 5.88 | -7.20 |
Loading charts...
Drawdowns
THRY vs. MDGL - Drawdown Comparison
The maximum THRY drawdown since its inception was -94.96%, roughly equal to the maximum MDGL drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for THRY and MDGL.
Loading charts...
Drawdown Indicators
| THRY | MDGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.96% | -98.40% | +3.44% |
Max Drawdown (1Y)Largest decline over 1 year | -84.84% | -29.36% | -55.48% |
Max Drawdown (3Y)Largest decline over 3 years | -91.69% | -49.34% | -42.35% |
Max Drawdown (5Y)Largest decline over 5 years | -94.96% | -61.41% | -33.55% |
Max Drawdown (10Y)Largest decline over 10 years | — | -82.19% | — |
Current DrawdownCurrent decline from peak | -91.92% | -14.92% | -77.00% |
Average DrawdownAverage peak-to-trough decline | -47.69% | -58.48% | +10.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.42% | 13.56% | +41.86% |
Volatility
THRY vs. MDGL - Volatility Comparison
Thryv Holdings, Inc. (THRY) has a higher volatility of 19.49% compared to Madrigal Pharmaceuticals, Inc. (MDGL) at 13.40%. This indicates that THRY's price experiences larger fluctuations and is considered to be riskier than MDGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THRY | MDGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.49% | 13.40% | +6.09% |
Volatility (6M)Calculated over the trailing 6-month period | 81.34% | 31.78% | +49.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 84.81% | 46.00% | +38.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.55% | 133.47% | -78.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.26% | 117.50% | -56.24% |
Dividends
THRY vs. MDGL - Dividend Comparison
Neither THRY nor MDGL has paid dividends to shareholders.
Financials
THRY vs. MDGL - Financials Comparison
This section allows you to compare key financial metrics between Thryv Holdings, Inc. and Madrigal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
THRY vs. MDGL - Profitability Comparison
THRY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Thryv Holdings, Inc. reported a gross profit of 109.26M and revenue of 167.68M. Therefore, the gross margin over that period was 65.2%.
MDGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a gross profit of 284.49M and revenue of 311.34M. Therefore, the gross margin over that period was 91.4%.
THRY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Thryv Holdings, Inc. reported an operating income of 4.06M and revenue of 167.68M, resulting in an operating margin of 2.4%.
MDGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported an operating income of -92.72M and revenue of 311.34M, resulting in an operating margin of -29.8%.
THRY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Thryv Holdings, Inc. reported a net income of 4.54M and revenue of 167.68M, resulting in a net margin of 2.7%.
MDGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a net income of -94.39M and revenue of 311.34M, resulting in a net margin of -30.3%.
Frequently Asked Questions
THRY and MDGL have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
THRY has higher volatility (19.49%) compared to MDGL (13.40%). In terms of maximum drawdown, THRY dropped -94.96% vs MDGL's -98.40%.
MDGL currently has the higher Sharpe Ratio (1.74 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THRY and MDGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer